Difference between revisions of "Category:MTOR inhibitors"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m (Text replacement - "Category:Serine/threonine kinase inhibitors" to "Category:Serine-threonine kinase inhibitors")
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
 
A class of drugs that inhibit the protein products of the mechanistic target of rapamycin (serine/threonine kinase) [MTOR] gene, in one or both of their structurally distinct complexes (mTORC1 and mTORC2).
 
A class of drugs that inhibit the protein products of the mechanistic target of rapamycin (serine/threonine kinase) [MTOR] gene, in one or both of their structurally distinct complexes (mTORC1 and mTORC2).
  
[[Category:Immunosuppresants]]
+
[[Category:Immunosuppressants]]
[[Category:Kinase inhibitors]]
+
[[Category:Serine-threonine kinase inhibitors]]

Latest revision as of 16:11, 24 February 2021

A class of drugs that inhibit the protein products of the mechanistic target of rapamycin (serine/threonine kinase) [MTOR] gene, in one or both of their structurally distinct complexes (mTORC1 and mTORC2).

Pages in category "MTOR inhibitors"

The following 4 pages are in this category, out of 4 total.